144 related articles for article (PubMed ID: 4077281)
1. 1-hydroxypyrene in human urine after exposure to coal tar and a coal tar derived product.
Jongeneelen FJ; Anzion RB; Leijdekkers CM; Bos RP; Henderson PT
Int Arch Occup Environ Health; 1985; 57(1):47-55. PubMed ID: 4077281
[TBL] [Abstract][Full Text] [Related]
2. Biological monitoring of polycyclic aromatic hydrocarbons. Metabolites in urine.
Jongeneelen FJ; Bos RP; Anzion RB; Theuws JL; Henderson PT
Scand J Work Environ Health; 1986 Apr; 12(2):137-43. PubMed ID: 3726495
[TBL] [Abstract][Full Text] [Related]
3. Biological monitoring of human exposure to coal tar. Urinary excretion of total polycyclic aromatic hydrocarbons, 1-hydroxypyrene and mutagens in psoriatic patients.
Clonfero E; Zordan M; Venier P; Paleologo M; Levis AG; Cottica D; Pozzoli L; Jongeneelen FJ; Bos RP; Anzion RB
Int Arch Occup Environ Health; 1989; 61(6):363-8. PubMed ID: 2744865
[TBL] [Abstract][Full Text] [Related]
4. A guidance value of 1-hydroxypyrene in urine in view of acceptable occupational exposure to polycyclic aromatic hydrocarbons.
Jongeneelen FJ
Toxicol Lett; 2014 Dec; 231(2):239-48. PubMed ID: 24831967
[TBL] [Abstract][Full Text] [Related]
5. Airborne concentrations, skin contamination, and urinary metabolite excretion of polycyclic aromatic hydrocarbons among paving workers exposed to coal tar derived road tars.
Jongeneelen FJ; Scheepers PT; Groenendijk A; Van Aerts LA; Anzion RB; Bos RP; Veenstra SJ
Am Ind Hyg Assoc J; 1988 Dec; 49(12):600-7. PubMed ID: 3213813
[TBL] [Abstract][Full Text] [Related]
6. [Longitudinal study of the excretion of 1-hydroxypyrene in urine after external treatment with coal tar].
Nenoff P; Richter B; Will W; Haustein UF
Hautarzt; 1997 Apr; 48(4):240-5. PubMed ID: 9206711
[TBL] [Abstract][Full Text] [Related]
7. Highly increased urinary 1-hydroxypyrene excretion rate in patients with atopic dermatitis treated with topical coal tar.
Veenhuis RT; van Horssen J; Bos RP; Anzion RB; Van Der Valk PG
Arch Dermatol Res; 2002 Jul; 294(4):168-71. PubMed ID: 12111346
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of polycyclic aromatic hydrocarbons, 1-hydroxypyrene, and mutagenicity in urine of coal tar-treated psoriasis patients and untreated volunteers.
Santella RM; Nunes MG; Blaskovic R; Perera FP; Tang D; Beachman A; Lin JH; DeLeo VA
Cancer Epidemiol Biomarkers Prev; 1994 Mar; 3(2):137-40. PubMed ID: 8049634
[TBL] [Abstract][Full Text] [Related]
9. The relationship between polycyclic aromatic hydrocarbons in air and in urine of workers in a Söderberg potroom.
Tjoe Ny E; Heederik D; Kromhout H; Jongeneelen F
Am Ind Hyg Assoc J; 1993 Jun; 54(6):277-84. PubMed ID: 8328359
[TBL] [Abstract][Full Text] [Related]
10. Nonselective and selective methods for biological monitoring of exposure to coal-tar products.
Bos RP; Jongeneelen FJ
IARC Sci Publ; 1988; (89):389-95. PubMed ID: 3198226
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal study of excretion of metabolites of polycyclic aromatic hydrocarbons in urine from two psoriatic patients.
Hansen AM; Poulsen OM; Menné T
Acta Derm Venereol; 1993 Jun; 73(3):188-90. PubMed ID: 8105615
[TBL] [Abstract][Full Text] [Related]
12. Patterns of 1-hydroxypyrene excretion in volunteers exposed to pyrene by the dermal route.
Viau C; Vyskocil A
Sci Total Environ; 1995 Feb; 163(1-3):187-90. PubMed ID: 7716497
[TBL] [Abstract][Full Text] [Related]
13. 1-Hydroxypyrene in urine as a biological indicator of exposure to polycyclic aromatic hydrocarbons in several work environments.
Jongeneelen FJ; Anzion RB; Scheepers PT; Bos RP; Henderson PT; Nijenhuis EH; Veenstra SJ; Brouns RM; Winkes A
Ann Occup Hyg; 1988; 32(1):35-43. PubMed ID: 3369793
[No Abstract] [Full Text] [Related]
14. Urinary 1-naphthol and 1-pyrenol as indicators of exposure to coal tar products.
Heikkilä P; Luotamo M; Pyy L; Riihimäki V
Int Arch Occup Environ Health; 1995; 67(3):211-7. PubMed ID: 7591181
[TBL] [Abstract][Full Text] [Related]
15. 1-Hydroxypyrene as an indicator of the mutagenicity of coal tar after activation with human liver preparations.
Jongeneelen FJ; vd Akker W; Bos RP; Anzion RB; Theuws JL; Roelofs HM; Henderson PT
Mutat Res; 1988 Feb; 204(2):195-201. PubMed ID: 3278210
[TBL] [Abstract][Full Text] [Related]
16. Significance of dermal and respiratory uptake in creosote workers: exposure to polycyclic aromatic hydrocarbons and urinary excretion of 1-hydroxypyrene.
Elovaara E; Heikkilä P; Pyy L; Mutanen P; Riihimäki V
Occup Environ Med; 1995 Mar; 52(3):196-203. PubMed ID: 7735394
[TBL] [Abstract][Full Text] [Related]
17. Uptake of pyrene in a breast-fed child of a mother treated with coal tar.
Scheepers PT; van Houtum JL; Anzion RB; Harder R; Bos RP; van der Valk PG
Pediatr Dermatol; 2009; 26(2):184-7. PubMed ID: 19419468
[TBL] [Abstract][Full Text] [Related]
18. Inhalation and dermal exposure of workers during timber impregnation with creosote and subsequent processing of impregnated wood.
Hebisch R; Karmann J; Schäferhenrich A; Göen T; Berger M; Poppek U; Roitzsch M
Environ Res; 2020 Feb; 181():108877. PubMed ID: 31722805
[TBL] [Abstract][Full Text] [Related]
19. A rapid and simple method for the analysis of 1-hydroxypyrene glucuronide: a potential biomarker for polycyclic aromatic hydrocarbon exposure.
Singh R; Tucek M; Maxa K; Tenglerová J; Weyand EH
Carcinogenesis; 1995 Dec; 16(12):2909-15. PubMed ID: 8603463
[TBL] [Abstract][Full Text] [Related]
20. Biological monitoring of human exposure to coal tar. Urinary mutagenicity assays and analytical determination of polycyclic aromatic hydrocarbon metabolites in urine.
Clonfero E; Jongeneelen F; Zordan M; Levis AG
IARC Sci Publ; 1990; (104):215-22. PubMed ID: 2228119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
